NovoCure (NVCR) Cash & Equivalents Growth (3y) (2017 - 2026)
NovoCure (NVCR) Cash & Equivalents Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | -13.31% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 34.27% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 8.16% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 40.74% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | -2.57% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 2.72% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 38.28% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 32.23% |
| 10 | NovoCure | 2.03 Bn | 1.59 Bn | 142.48 Mn | -15.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.80% |
| Mar 31, 2026 | -22.21% |
| Dec 31, 2025 | -6.74% |
| Sep 30, 2025 | 11.96% |
| Jun 30, 2025 | -25.85% |
| Mar 31, 2025 | -12.61% |
| Dec 31, 2024 | -7.78% |
| Sep 30, 2024 | -35.46% |
| Jun 30, 2024 | -22.14% |
| Mar 31, 2024 | 12.99% |
| Dec 31, 2023 | 0.87% |
| Sep 30, 2023 | -12.91% |
| Jun 30, 2023 | -7.26% |
| Mar 31, 2023 | 0.74% |
| Dec 31, 2022 | -13.36% |
| Sep 30, 2022 | 5.43% |
| Jun 30, 2022 | 26.79% |
| Mar 31, 2022 | 7.85% |
| Dec 31, 2021 | 14.08% |
| Sep 30, 2021 | 77.69% |